Showing 2451-2460 of 2652 results for "".
- Long-Term Pentosan Polysulfate Sodium Use Tied to Macular Diseasehttps://modernod.com/news/long-term-pentosan-polysulfate-sodium-use-tied-to-macular-disease/2477106/Use of the interstitial cystitis drug pentosan polysulfate sodium (PPS) was associated with a new diagnosis of macular disease at the 7-year follow-up in a large retrospective matched cohort study, according to a Reuters report. 
- Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma to Advance Its Dry Eye Programhttps://modernod.com/news/aerie-pharmaceuticals-announces-agreement-to-acquire-avizorex-pharma-to-advance-its-dry-eye-program/2477097/Aerie Pharmaceuticals announced it is acquiring Avizorex Pharma, a Spanish ophthalmic pharmaceutical company developing therapeutics for the treatment of dry eye disease. AVX completed a phase 2a study in dry eye subjects earlier this year with its lead product candidate, AVX-012. The acti
- Understanding the Eye’s ‘Plumbing’ Could Lead to Future Treatments for Glaucoma, Other Diseaseshttps://modernod.com/news/understanding-the-eyes-plumbing-could-lead-to-future-treatments-for-glaucoma-other-diseases/2477092/Scientists in the University of Arizona Department of Physiology have identified a potential molecular mechanism that may hold the key to understanding how pressure is regulated in the eye. Funded by a $2.3 million 5-year grant from the National Institutes of Health (NIH) National Eye Inst
- Intravitreous Ranibizumab Cost-Effective for Some With Proliferative Diabetic Retinopathyhttps://modernod.com/news/intravitreous-ranibizumab-cost-effective-for-some-with-proliferative-diabetic-retinopathy/2477079/At 5 years, intravitreous ranibizumab therapy for proliferative diabetic retinopathy (DR) appears to be cost-effective relative to panretinal photocoagulation (PRP), but only in eyes with vision-impairing center-involved diabetic macular edema (CI-DME), according to new findings
- Vision Plan Customer Satisfaction Increases, J.D. Power Findshttps://modernod.com/news/vision-plan-customer-satisfaction-increases-j-d-power-finds/2477073/Overall customer satisfaction among vision plan members has increased in 2019, driven by improved perceptions of value and coverage. According to the J.D. Power 2019 Vision Plan Satisfaction Report, overall satisfaction increased by 17 points (on a 1,000-point scale) to 770 this year from 753 in
- Adverum Biotechnologies Doses First Patient in Third Cohort of OPTIC Clinical Trial of Intravitreal Gene Therapy for Wet AMDhttps://modernod.com/news/adverum-biotechnologies-doses-first-patient-in-third-cohort-of-optic-phase-1-clinical-trial-of-advm-022-intravitreal-gene-therapy-for-wet-amd/2477039/Adverum Biotechnologies announced that the first patient was dosed in the third cohort (n=9) of the ongoing OPTIC phase 1 clinical trial for ADVM-022 for the treatment of neovascular age-related macular degeneration (AMD). Patients in this cohort are receiving a single intravitreal injection of g
- Sight Sciences: International MIGS Study Confirms Long-Term Safety and Efficacy of the OMNI Surgical System Predicate Device (VISCO360)https://modernod.com/news/sight-sciences-international-migs-study-confirms-long-term-safety-and-efficacy-of-the-omni-surgical-system-predicate-device-visco360/2477032/Sight Sciences announced a new, single center study of glaucoma surgery patients published in the July 2019 issue of Clinical Ophthalmology, which shows that ab-interno microcatheterization and 360˚ viscodilation of Schlemm’s Canal using one of the OMNI
- Visual Learning Assessments Enable Optometrists to Offer Second Opinion on Child Learning Disordershttps://modernod.com/news/righteye-helps-fight-neurological-disorders-traumatic-brain-injury-and-learning-disabilities-with-database-of-one-billion-eye-tracking-data-points/2477028/RightEye announced that it has released a new educational guide–Reading & Learning: Guide to Growing Your Optometry Practice–designed to help optometrists realize the benefits of integrating visual learning assessments into their practices. This guide provides tips on different ways that opto
- New Approach to Slowing Nearsightedness in Children Shows Promisehttps://modernod.com/news/new-approach-to-slowing-nearsightedness-in-children-shows-promise/2477006/Combining two different treatment methods to slow the progression of myopia may deliver better results than either can achieve on their own. A new, 2-year study shows that treating children with eye drops and contact lenses was 28 percent to 38 percent more effective in slowing myopia. The resear
- Optos Unveils Silverstone Combined Ultra-Widefield Retinal Imaging Device and UWF-Guided Swept Source OCThttps://modernod.com/news/optos-unveils-silverstone-combined-ultra-widefield-retinal-imaging-device-and-uwf-guided-swept-source-oct/2476998/Optos has announced the launch of Silverstone at the American Academy of Ophthalmology in San Francisco. Silverstone is the first-of-its-kind, combining world-leading ultra-widefield retinal imaging with integrated, image-guided, swept source OCT. Silverstone produces a 200° single capture